ReviewKidney diseases (Basel, Switzerland)
Research Progress of Natural Products Targeting Macrophages in the Treatment of Diabetic Kidney Disease.
Review in Kidney diseases (Basel, Switzerland). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic kidney disease (DKD) has emerged as the leading cause of end-stage renal disease (ESRD) internationally due to the rising prevalence of diabetes mellitus. DKD is not only a secondary disease caused by continuous glucose metabolism disorder but also a chronic inflammatory disease characterized by high expression of pro-inflammatory factors and a large number of immune cell infiltration. Macrophages are the main immune cells infiltrating in the kidney, which can polarize into pro-inflammatory M1 and anti-inflammatory M2 phenotypes under the high control of the surrounding microenvironment. M1 and M2 macrophages can coexist at times but have distinct functional characteristics in the same population. Summary: Studies have confirmed that the accumulation and polarization of macrophages is a risk factor for the progression of DKD. Natural products contribute to alleviate kidney damage by suppressing macrophage recruitment and activation, which may be a potential treatment for DKD. Key Messages: This review describes the phenotype and polarization of macrophages, as well as their role in DKD animal models and patients, outlines the molecular mechanism of macrophage recruitment and activation in DKD, further discusses the cross-action between macrophages and other kidney cells, and emphatically summarizes natural products targeting macrophages, which is of great significance for future basic research and clinical management of DKD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.